These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32885610)

  • 1. Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication.
    Hollingsworth R; El Guerche-Séblain C; Tsai T; Vasiliev Y; Lee S; Bright H; Barbosa P
    Influenza Other Respir Viruses; 2021 Jan; 15(1):164-174. PubMed ID: 32885610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Influenza Vaccination in Preventing Hospitalization Due to Influenza in Children: A Systematic Review and Meta-analysis.
    Boddington NL; Pearson I; Whitaker H; Mangtani P; Pebody RG
    Clin Infect Dis; 2021 Nov; 73(9):1722-1732. PubMed ID: 33772586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.
    Rondy M; Puig-Barbera J; Launay O; Duval X; Castilla J; Guevara M; Costanzo S; de Gaetano Donati K; Moren A
    PLoS One; 2013; 8(4):e59681. PubMed ID: 23565159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States.
    Valenciano M; Ciancio B; Moren A;
    Euro Surveill; 2008 Oct; 13(43):. PubMed ID: 18947520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria.
    Redlberger-Fritz M; Kundi M; Popow-Kraupp T
    Front Immunol; 2020; 11():434. PubMed ID: 32256493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France.
    Souty C; Vilcu AM; Capai L; van der Werf S; Valette M; Blanchon T; Lina B; Behillil S; Hanslik T; Falchi A
    J Clin Virol; 2017 Oct; 95():1-4. PubMed ID: 28818690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    Darvishian M; Dijkstra F; van Doorn E; Bijlsma MJ; Donker GA; de Lange MM; Cadenau LM; Hak E; Meijer A
    PLoS One; 2017; 12(1):e0169528. PubMed ID: 28068386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network.
    Puig-Barberà J; Natividad-Sancho A; Launay O; Burtseva E; Ciblak MA; Tormos A; Buigues-Vila A; Martínez-Úbeda S; Sominina A;
    PLoS One; 2014; 9(6):e100497. PubMed ID: 24945510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengths and limitations of assessing influenza vaccine effectiveness using routinely collected, passive surveillance data in Ontario, Canada, 2007 to 2012: balancing efficiency versus quality.
    Savage RD; Winter AL; Rosella LC; Olsha R; Gubbay JB; Skowronski DM; Crowcroft NS
    Euro Surveill; 2015 Apr; 20(16):. PubMed ID: 25953275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    van Doorn E; Darvishian M; Dijkstra F; Donker GA; Overduin P; Meijer A; Hak E
    Vaccine; 2017 May; 35(21):2831-2839. PubMed ID: 28412077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
    Darvishian M; van den Heuvel ER; Bissielo A; Castilla J; Cohen C; Englund H; Gefenaite G; Huang WT; la Bastide-van Gemert S; Martinez-Baz I; McAnerney JM; Ntshoe GM; Suzuki M; Turner N; Hak E
    Lancet Respir Med; 2017 Mar; 5(3):200-211. PubMed ID: 28189522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Stuurman AL; Biccler J; Carmona A; Descamps A; Díez-Domingo J; Muñoz Quiles C; Nohynek H; Rizzo C; Riera-Montes M;
    Vaccine; 2021 Jun; 39(29):3964-3973. PubMed ID: 34092427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
    Leval A; Hergens MP; Persson K; Örtqvist Å
    Euro Surveill; 2016 Oct; 21(43):. PubMed ID: 27813473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project.
    Stuurman AL; Levi M; Beutels P; Bricout H; Descamps A; Dos Santos G; McGovern I; Mira-Iglesias A; Nauta J; Torcel-Pagnon L; Biccler J;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13087. PubMed ID: 36550627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-MOVE: a European network to measure the effectiveness of influenza vaccines.
    Valenciano M; Ciancio B;
    Euro Surveill; 2012 Sep; 17(39):. PubMed ID: 23041022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19.
    Stuurman AL; Bollaerts K; Alexandridou M; Biccler J; Díez Domingo J; Nohynek H; Rizzo C; Turunen T; Riera-Montes M;
    Vaccine; 2020 Sep; 38(41):6455-6463. PubMed ID: 32778474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season.
    Mira-Iglesias A; López-Labrador FX; García-Rubio J; Mengual-Chuliá B; Tortajada-Girbés M; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33514058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Thompson MG; Pierse N; Sue Huang Q; Prasad N; Duque J; Claire Newbern E; Baker MG; Turner N; McArthur C;
    Vaccine; 2018 Sep; 36(39):5916-5925. PubMed ID: 30077480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.